CHC Healthcare Group (TPE:4164)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.45
+0.45 (1.36%)
Feb 11, 2026, 1:30 PM CST

CHC Healthcare Group Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
161.42168.38418.87356.57381.63366.39
Depreciation & Amortization
654.64633.97594.46499.38460.59440.91
Other Amortization
12.189.249.8710.6510.5713.92
Loss (Gain) From Sale of Assets
-1.97-2.091.33-55.81-31.50.69
Loss (Gain) From Sale of Investments
4.65-4.03-13.0917.990.96-37.38
Loss (Gain) on Equity Investments
3.77-1-1.60.33-8.640.28
Stock-Based Compensation
--0.291.763.214.46
Provision & Write-off of Bad Debts
6.33-2.040.284.160.320.89
Other Operating Activities
52.16-107.4449.9532.786.8225.52
Change in Accounts Receivable
15.23-294.76-126.88-168.179.6648.41
Change in Inventory
-342.37-255.6-76.69-209.237.16121.27
Change in Accounts Payable
212.3662.6748.7128.5526.77-68
Change in Unearned Revenue
280.75148.0948.658.19-115.2440.82
Change in Other Net Operating Assets
-237.94-278.4924.94-1.28-144.25-45.33
Operating Cash Flow
814.0999.37962.59656.66692.8916.03
Operating Cash Flow Growth
76.29%-89.68%46.59%-5.22%-24.37%-24.62%
Capital Expenditures
-753.23-431.09-549.67-682.63-514.09-721.26
Sale of Property, Plant & Equipment
11.4511.051.071.24-2.59
Cash Acquisitions
-34.08-39.25-49.52--315.03-
Divestitures
0.2475----
Sale (Purchase) of Intangibles
-5.2--26---
Sale (Purchase) of Real Estate
-25.2-44.71-29.39163.9451.97-10.72
Investment in Securities
-108.52-17.59143.65133.1-74.1269.39
Other Investing Activities
-170.92-98.279.444.38-139.09-71.63
Investing Cash Flow
-1,085-544.86-500.47-339.98-990.35-731.63
Short-Term Debt Issued
-2,8502,1043,4813,4183,040
Long-Term Debt Issued
-197.62515.942,635611.192,594
Total Debt Issued
6,1783,0472,6206,1164,0295,634
Short-Term Debt Repaid
--2,352-2,058-3,778-2,972-3,321
Long-Term Debt Repaid
--252.73-305.36-2,372-448.09-2,082
Total Debt Repaid
-5,642-2,605-2,363-6,150-3,420-5,403
Net Debt Issued (Repaid)
536.12442.32256.93-33.7609.07231.32
Issuance of Common Stock
1.070.7818.3714.36174.488.24
Common Dividends Paid
-251.97-334.5-324.72-323.88-313.65-281.27
Other Financing Activities
28.3979.647.37-3.23-54.84-9.6
Financing Cash Flow
313.61188.24-42.05-346.45415.06-51.32
Foreign Exchange Rate Adjustments
-6.137.65-1.548.69-4.092.2
Net Cash Flow
36.11-249.6418.53-21.08113.41135.29
Free Cash Flow
60.86-331.72412.92-25.97178.7194.77
Free Cash Flow Growth
25.77%----8.25%-77.64%
Free Cash Flow Margin
1.45%-9.21%10.65%-0.87%7.32%7.62%
Free Cash Flow Per Share
0.33-1.702.13-0.140.960.97
Cash Interest Paid
104.196.0786.2353.8847.4660.43
Cash Income Tax Paid
71.5190.56107.89110.82110.3579.37
Levered Free Cash Flow
-328.54-338.76401.21-72.858.2165.14
Unlevered Free Cash Flow
-276.05-293.26439.67-46.6478.99192.11
Change in Working Capital
-79.09-595.62-97.77-211.16-131.16100.35
Source: S&P Global Market Intelligence. Standard template. Financial Sources.